Clinical Trial Update: A Study Evaluating the Safety, Pharmacokinetics, and Antiviral Efficacy of SB 9200 in Subjects Infected With Chronic HBV [Phase 2]

View source ↗

Summary

APhase 2 clinical trial evaluating safety, pharmacokinetics, and antiviral efficacy of SB 9200 in subjects with chronic hepatitis B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• Viral Hepatitis

Drugs mentioned

• SB 9200

Snippet

Sponsor: F-star Therapeutics, Inc. | Conditions: Hepatitis B, Hepatitis, Viral | Phase 2 | Status: COMPLETED